CEACAM5 and familial pancreatic carcinoma: In addition to the pretreatment serum hemoglobin levels, initial serum carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA) and lactate dehydrogenase (LDH) levels have been identified as significant prognostic factors in different stages of pancreatic cancer.